Zimmer Biomet Holdings, Inc. ZBH
91.04
1.35
1.51%
as of 25 Sep
- Market cap
- $17.1B
- P/E
- 22.0×
Follow ZBH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Zimmer Biomet Holdings, Inc. (ZBH) Revenue growth
Zimmer Biomet Holdings, Inc.'s revenue growth over the twelve months to 30 June 2026 was 8.62%, up 1.4 percentage points from fiscal 2025 (7.20%). Over the past ten years it has ranged from −23.2% (fiscal 2020) to 28.3% (fiscal 2015); the current reading is higher than 73% of that period. That is in line with the Medical Devices industry median of 8.80% and in line with the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 7.20% | 3.35 |
| FY2024 | 3.85% | (2.70) |
| FY2023 | 6.55% | 4.90 |
| FY2022 | 1.65% | (9.77) |
| FY2021 | 11.4% | 34.66 |
| FY2020 | −23.2% | (23.86) |
| FY2019 | 0.62% | (1.04) |
| FY2018 | 1.66% | (0.10) |
| FY2017 | 1.76% | (26.09) |
| FY2016 | 27.9% | (0.49) |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 4.80% | (4.50) |
| Mar 2026 | 9.30% | (1.60) |
| Dec 2025 | 10.9% | 1.19 |
| Sep 2025 | 9.71% | 2.74 |
| 42 more quarters | Free account |
Against its own ten years
Low −23.2%
High 28.3%
Ten-year median
3.85%
Current reading's percentile
73
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| GMED Globus Medical, Inc. compare | 19.7% |
| PEN Penumbra, Inc. compare | 17.6% |
| PHG Koninklijke Philips N.V. compare | 9.11% |
| ZBH Zimmer Biomet Holdings, Inc. | 8.62% |
| STE STERIS plc compare | 8.37% |
| GEHC GE HealthCare Technologies Inc. compare | 6.51% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| BIO Bio-Rad Laboratories, Inc. compare | 1.37% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 1.37% |
| Medical Devices industry median | 8.80% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on ZBH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement